Global Dental Biomaterials Market – Industry Trends and Forecast to 2023

The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. 

Download Free Brochures -

Implantology applications to dominate the dental biomaterials market through the forecast period

By application, the market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.

Dental implant and prosthetic manufacturers to hold the largest share of the dental biomaterial market during the forecast period

Based on the end user, the market is segmented into dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices, and the rising awareness on oral diseases.

Request for Sample Report for detailed information -

Key Market Players

The prominent players in the global market are Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).

Straumann is among the leading players in the dentistry industry. It is a global provider of dental products utilized in implants, restorative dentistry products, and oral tissue generation therapy. The company has a strong brand value and an established geographical presence. In 2017, Straumann reported an increase of 21% in its revenue, compared to 2016. The company is expected to grow further in the coming years due to its increasing focus on countries such as China, India, Argentina, Chile, and Colombia. Straumann significantly invests in R&D, sales, and marketing activities to drive innovation and to capture the growth potential in underpenetrated markets. In order to increase its customer base and maintain its position in the market, the company focuses on various growth strategies such as acquisitions, agreements, and product launches.

Key question addressed by the report

  • Who are the top 10 players operating market?
  • What are the driving factors, restraints, opportunities, and challenges in market?
  • What are the industry trends and current scenario of the market?
  • What are the growth trends in market at segmental and overall market levels?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst